Repligen Corp

Repligen insider buys signal confidence: Pax Margaret and other executives buy 995 shares + options, boosting long‑term optimism amid volatile biotech markets.

CEO Loeillot Olivier sells 3,832 Repligen shares just before Q1 earnings, raising questions on the stock’s high valuation and potential future upside.

Repligen COO buys 125 shares, sells 62 to cover taxes – a confidence boost amid a 17.5% monthly dip, showing insider trust in future bioprocessing gains.